A postmarketing safety programme for generic ticlopidine is being considered by the US FDA News item 18 January 2013 Pages: 2 - 2
The US FDA has requested proposals for an active postmarketing surveillance hospital pilot programme News item 18 January 2013 Pages: 2 - 2
An increase in the number of `Dear Healthcare Professional' letters regarding adverse events News item 18 January 2013 Pages: 3 - 3
Computers identify patients at risk for drug related problems Clinical study 18 January 2013 Pages: 3 - 3
More education needed about drug therapy during pregnancy Clinical study 18 January 2013 Pages: 3 - 3
Antioxidants such as acetylcysteine may be useful for reducing cyclosporin nephrotoxicity Animal 18 January 2013 Pages: 4 - 4
Bezafibrate may be beneficial in patients with tamoxifen-induced non-alcoholic steatohepatitis Correspondence 18 January 2013 Pages: 4 - 4
Melatonin protects against cyclosporin-induced nephrototoxicity in rats Animal 18 January 2013 Pages: 4 - 4
NSAID-induced anaphylactic reactions are associated with HLA-DRB1 genes Clinical study 18 January 2013 Pages: 4 - 4
Riluzole may be useful for the treatment of levodopa-induced dyskinesias Comment 18 January 2013 Pages: 4 - 4
Nicorandil not associated with increased incidence of diabetes Clinical study 18 January 2013 Pages: 5 - 5
Ibuprofen may be linked with necrotising fasciitis in children Clinical study 18 January 2013 Pages: 6 - 6
No tumours were detected in infants who were exposed in utero or neonatally to zidovudine Incidence study 18 January 2013 Pages: 6 - 6
OC use increases risk of gestational trophoblastic tumours Incidence study 18 January 2013 Pages: 6 - 6
